Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

121.16
Delayed Data
As of Feb 17
 +2.50 / +2.11%
Today’s Change
94.39
Today|||52-Week Range
127.00
+4.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line800.7M598.2M171.4M428.9M
 
 
 
 
 
Depreciation125.3M125.3M115.9M138.2M
 
 
 
 
 
Total Other Cash Flow187.4M200.8M430.7M452.0M
 
 
 
 
 
Funds From Operations1.1B801.0M627.9M931.9M
 
 
 
 
 
Funds From/For Other Operating Expenses95.1M-135.0M-94.6M-411.0M
 
 
 
 
 
Net Cash Flow - Operating Activities974.9M936.0M722.5M1.3B
 
 
 
 
 
 
InvestingIncrease In Investments-364.8M-156.8M-160.8M-730.4M
 
 
 
 
 
Decrease In Investments314.2M125.1M115.5M92.6M
 
 
 
 
 
Capital Expenditures-59.6M-43.7M-66.5M-66.4M
 
 
 
 
 
Other Investing - Uses0.000.00-600.0K0.00
 
 
Net Cash Flow Investing-110.2M-75.4M-112.4M-704.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings------0.00--
Long Term Debt Reduction------0.00--
Net Proceeds Stock Sale65.2M16.5M116.7M168.3M
 
 
 
 
 
Common Preferred Redeemed-1.4B-296.3M-320.1M-133.6M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing25.1M57.0M47.7M59.0M
 
 
 
 
 
Other Uses - Financing0.000.000.0041.1M
 
 
Net Cash Flow - Financing-1.3B-222.8M-155.7M52.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash20.2M-19.6M4.5M-44.0M
 
 
 
 
 
 
Net Change In Cash-455.0M637.8M454.4M691.3M